Oxford and AstraZeneca: the reprise of COVID-19 vaccine trial

AstraZeneca says should know if vaccine works by year-end if trials resume

A sign marks an Astra Zeneca facility in WalthamMore

According to a statement by AstraZeneca on Saturday, an independent expert committee in the United Kingdom set up to review the issue had concluded investigations and recommended to the Medicines Health Regulatory Authority (MHRA) that the trials are "safe to resume".

What Happened: The U.K. pharma giant said U.K. regulatory agency, the Medicines Health Regulatory Authority (MHRA) has given its concurrence to resume the late-stage study of AZD1222 - the vaccine candidate it is jointly developing with the Oxford University against SARS-CoV-2.

The Serum Institute of India (SII) on Saturday said phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate will resume after receiving the green signal from the Drugs Controller General of India (DCGI).

However the University said: "In large trials such as this, it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety".

Matt Hancock, UK's health secretary, said the initial pause of the trials showed that safety will always come first.

Receiving A Flu Shot Is Encouraged During Pandemic
Song says the impact of school closures on the spread of COVID-19 among children is the next area of study for her research team. They're not anti-vaccine - that's a different group - they're just not as convinced about the merits of vaccination".

On the 2nd September, it was reported that "A new arm of the ongoing global clinical trials of the ChAdOx1 nCoV-19 vaccine led by AstraZeneca has launched in the U.S. to assess safety, efficacy and immunogenicity of the vaccine for the prevention of COVID-19".

According to the statement, the trials have been carried out in three other countries: Bahrain, the UAE and Jordan.

The Oxford-based biotech company was co-founded by Mark Howarth and his team at Oxford University's Department of Biochemistry and spun out with the help of Jenner Institute vaccinologists Biswas, Simon Draper and Jing Jin in 2017.

China has approved for trials its first nasal spray vaccine to combat the novel coronavirus that has claimed over 904,000 lives and infected more than 27 million people globally, official media here reported on Thursday.

"This temporary pause is living proof that we follow those principles while a single event at one of our trial sites is assessed by a committee of independent experts", said Soriot.

Nine new cases of Covid-19 in Kildare today
Of the cases notified today 160 are men and 146 are women while 73% are under 45 years of age. There is now a total of 29,672 confirmed cases of COVID-19 in Ireland.

"The first batches of the vaccine for testing the supply chain have already been shipped, we are now checking the delivery system so that the staff gets to know it".

After cases of human-to-human transmissions were confirmed outside of China, the World Health Organization (WHO) declared the coronavirus outbreak an global public health emergency, but due to a sharp surge in cases, it was soon forced to issue a new statement declaring the outbreak a pandemic.

"To tackle the global COVID-19 pandemic, we need to develop vaccines and therapies that people feel comfortable using, therefore it is vital to maintaining public trust that we stick to the evidence and do not draw conclusions before information is available", she said.

Unlike many vaccines, the Imperial one is completely synthetic and uses the genetic instructions for the surface spiky protein of the virus.

Djokovic Stunningly Exits US Open
He was 26-0 this year heading into Sunday's affair and was the overwhelming favorite to capture his fourth US Open title. King was far from the only person to instantly declare Djokovic guilty of all charges without a second thought.

Latest News